Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.
about
Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agentsInhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivationEarly induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors.Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Bioavailability of hydroxychloroquine tablets in healthy volunteers.Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.The enigma of the clandestine association between chloroquine and HIV-1 infection.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.Chloroquine differentially modulates inflammatory cytokine expression in RAW 264.7 cells in response to inactivated Staphylococcus aureus.The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.Hematologic disposition of hydroxychloroquine enantiomers.Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes.Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
P2860
Q27302392-27B012E6-C033-4FAC-928A-D2C794F1FE75Q28329787-1A6D057A-9213-4DE7-83A2-0D6076400D95Q28379104-62C0FA86-BFC5-4523-9F20-CECA4236C727Q31893630-838642C2-7F13-44E5-A3F2-F108BA6457D0Q33613674-860A8967-1718-42E7-ABA1-613B0FCAD315Q34397314-E33955AB-C116-4F28-8259-B6FEEB3CB44AQ37627829-C515C79E-6C2E-4505-9385-109C77B5438DQ38559764-D068F82C-0FEF-45A6-9A3C-8DC6349AB019Q38561490-BA9DD304-05B5-4E99-B281-F7DEA2E8FA45Q41198004-A07AB49D-2424-4988-998D-8846DF48B3FDQ41855892-4A9574F4-D531-4F06-BD9C-552D59B1D7E6Q41920583-BE0698D5-3694-4B53-8FED-1656584C2D5CQ41934084-81FE0945-07D4-41F0-A80F-E73D1919CABAQ41934460-14FE983A-71FF-4A3F-8321-4213FD4FF8B5Q41945241-E3902188-6FF7-40CD-9C06-90D1BAFED092Q41946037-916C2272-98C6-44AC-BF7D-184ADABBCDE2
P2860
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@ast
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@en
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@nl
type
label
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@ast
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@en
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@nl
prefLabel
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@ast
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@en
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@nl
P2093
P2860
P356
P1476
Uptake of chloroquine and hydr ...... during antirheumatic therapy.
@en
P2093
P2860
P356
10.1136/ARD.46.1.42
P407
P577
1987-01-01T00:00:00Z